<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20110721007080N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-04</date_registration>
      <primary_sponsor>Babol University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effect of patient position change on the quality of colonoscopy</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the Effectiveness of changing patient's position during the Withdrawal phase of Colonoscopy from left lateral Decubitus to Supine on increasing Adenoma Detection Rate (ADR)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-04-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>624</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/46565</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Diagnostic, Randomization description: Patients will assign to study groups due to the random blocks method. By using a website(www.randomization.com) and considering one block and total sample size 624, all patients with a 1 to 1 ratio, randomly assigned to one of the study groups according to the patient's number. During the colonoscopy, at the beginning of the withdrawal phase, the physician will use the patient's list and put a patient in a considered group according to patient's number and continue the procedure, Blinding description: This study is a single-blind study.
Due to anesthesia, the patients are blind to the group they are in.
The physician performing the colonoscopy is blind to the patient group up to the beginning of the withdrawal phase of colonoscopy, but because of the nature of the colonoscopy process and the physician's direct view of how the patient is positioned, it is not possible to blind the physician during the withdrawal phase of colonoscopy.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Adenoma Detection Rate (ADR).</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: positioning the patient in supine position in the withdrawal phase of colonoscopy. At the beginning of the withdrawal phase of colonoscopy, patients will be switched from the left lateral position to the supine position by helping from the nurse, and the physician initiates the withdrawal phase of colonoscopy. Intervention 2: Control group: positioning the patient in the left lateral decubitus position in the withdrawal phase of colonoscopy. Patients will remain in the same position lying on their left side and the doctor will initiate the withdrawal phase of colonoscopy.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Epidemiological findings and gathered data from colonoscopy and pathology results after making participants anonymous are sharable.

When:
The start of access is 6 months after the publication of results.

To whom:
The data are accessible to other scientists.

Conditions:
The researcher must say the data are used in which research and specify the goal of the research.

Where to obtain:
For data access refer to the corresponding author.

How to obtain:
Request for data access is sent to the corresponding author and after investigation, if seeming fit, the data will be shared

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Javad Shokri Shirvani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rouhani haspital, Danesgah Square, Ganjafrooz Avenue, Babol</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۴۷۱۷۶-۴۷۷۴۵</zip>
        <telephone>+98 11 1223 8284</telephone>
        <email>drshokrij@mubabol.ac.ir</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Javad Shokri Shirvani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Rouhani haspital, Danesgah Square, Ganjafrooz Avenue, Babol</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۴۷۱۷۶-۴۷۷۴۵</zip>
        <telephone>+98 11 1223 8284</telephone>
        <email>drshokrij@mubabol.ac.ir</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age between 40 and 85 years
Recommended to  do screening colonoscopy</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>85 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of Colitis
History of Colonic Polyposis Syndrome
Familial history of Colorectal Cancer
History of Colectomy
History of Cholecystectomy
History of Endoscopic Retrograde Cholangiopancreatography (ERCP)
History of Colonoscopy in the past year
History of Inflammatory Bowel Disease
History of Opium use
Lack of Anesthesia for Colonoscopy
Difference in received Anesthesia Drug
Lack of Antispasmodic Medication for Colonoscopy
Differences in received Antispasmodic Drug
Difference in dose of received Antispasmodic Drug
Absence of a Nurse during Colonoscopy
Presence of a second physician during Colonoscopy
Musculoskeletal problems in Patient
Patient Dissatisfaction to Participate in the Study
Disapproval of reaching to Cecum by physician or requiring more than 20 minutes to reach the Cecum
Inadequate Bowel Preparation (The Boston Bowel Preparation Scale less than 5)
Occurrence of any Side Effects During the Colonoscopy procedure</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K63.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Polyp of colon</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Diagnosis</i_code>
      <i_code>Diagnosis</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: positioning the patient in supine position in the withdrawal phase of colonoscopy. At the beginning of the withdrawal phase of colonoscopy, patients will be switched from the left lateral position to the supine position by helping from the nurse, and the physician initiates the withdrawal phase of colonoscopy.</i_keyword>
      <i_keyword>Control group: positioning the patient in the left lateral decubitus position in the withdrawal phase of colonoscopy. Patients will remain in the same position lying on their left side and the doctor will initiate the withdrawal phase of colonoscopy.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Adenoma Detection Rate. Timepoint: The outcome variable will be calculated after doing colonoscopy for all specimens for both study groups. Method of measurement: The number of adenomas observed in the withdrawal phase for each patient will be recorded in the patient's pre-prepared form. After doing colonoscopy of all specimens, we calculate the adenoma detection rate for each group. It is the proportion of patients in whom more than one adenoma has been observed to all patients undergoing colonoscopy and will be calculated separately for each group.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>The Size of a Detected lesion. Timepoint: During Colonoscopy Procedure. Method of measurement: during the colonoscopy procedure, the diameter of the detected lesion will be measured in comparison to the biopsy forceps and will be recorded in the patient-specific form.</sec_outcome>
      <sec_outcome>Patient's feeling about Abdominal Fullness after Colonoscopy. Timepoint: 10 minutes after the patient recovered. Method of measurement: 10 minutes after the patient recovered, we will ask him or her about abdominal fullness by  using a prepared question which has 5 option from no abdominal fullness to painful fullness.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Babol University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-03-14</approval_date>
        <contact_name>Research Ethics Committee of Health Research Institute - Babol University of Medical Sciences</contact_name>
        <contact_address>Ganj Afroz St, Babol University of Medical Sciences, Health Research Institute Babol Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
